510(k) Report

510(k) · Cleared

Recalled · 2010

Depuy Asr XL Modular Acetabular Cup System

K080991510(k) TraditionalCleared Jul 2, 200886-day reviewClass III21 CFR 888.3330Recalls 41

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

DePuy Orthopaedics, Inc. · KWA Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component)

Cleared on Jul 2, 2008 as substantially equivalent to K040627 (DePuy Orthopaedics, Inc., 2005) and 6 other predicates after an 86-day review. Its family tree reaches back 6 generations to 1994. It has been recalled 41 times.

Decided
Jul 2, 2008
Review
86 days
Class
Class III
Product code
KWA
Recalls
41
Predicates
7

Its longest line of descent runs back 6 generations to K935452 (1994). 32 ancestors in all, the oldest K851422 (1985). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2008: 2 other ancestors2007: 1 other ancestor2005: 1 other ancestor2002: 1 other ancestor1997: 1 other ancestor2001: 1 other ancestor2000: 3 other ancestors1996: 4 other ancestors1998: 1 other ancestor1994: 3 other ancestors1995: 2 other ancestors1993: 2 other ancestors1985: 1 other ancestor1992: 2 other ancestors1991: 1 other ancestorK935452 · P.F.C. 2 Total Hip System Porous Coated Modular Femoral Component · Johnson & Johnson Orthopaedics, Inc. · 1994K945518 · P.F.C. 2 Total Hip System Porous Coated Modular Femoral Component · Johnson & Johnson Professionals, Inc. · 1996K961939 · S-Rom Femoral Hip Stem (Sizes 12 X 06 X 115 and 12 X 07 X 115) · Johnson & Johnson Professionals, Inc. · 1996K974331 · Uni-Rom Total Hip System Femoral Stem · Johnson & Johnson Professionals, Inc. · 1998K001991 · Titan Porocoat Hip Prosthesis · DePuy Orthopaedics, Inc. · 2000K042992 · Corail Amt Hip Prosthesis · DePuy Orthopaedics, Inc. · 2005 · recalled198519901995200020052010
  1. Root · 6 generations backK935452 P.F.C. 2 Total Hip System Porous Coated Modular Femoral ComponentJohnson & Johnson Orthopaedics, Inc. · 1994
  2. 5 generations backK945518 P.F.C. 2 Total Hip System Porous Coated Modular Femoral ComponentJohnson & Johnson Professionals, Inc. · 1996
  3. 4 generations backK961939 S-Rom Femoral Hip Stem (Sizes 12 X 06 X 115 and 12 X 07 X 115)Johnson & Johnson Professionals, Inc. · 1996
  4. 3 generations backK974331 Uni-Rom Total Hip System Femoral StemJohnson & Johnson Professionals, Inc. · 1998
  5. 2 generations backK001991 Titan Porocoat Hip ProsthesisDePuy Orthopaedics, Inc. · 2000
  6. 1 generation backK042992 Corail Amt Hip ProsthesisDePuy Orthopaedics, Inc. · 2005 · Recalled
  7. This deviceK080991 Depuy Asr XL Modular Acetabular Cup SystemDePuy Orthopaedics, Inc. · 2008
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K935452P.F.C. 2 Total Hip System Porous Coated Modular Femoral ComponentJohnson & Johnson Orthopaedics, Inc.1994—
−5K945518P.F.C. 2 Total Hip System Porous Coated Modular Femoral ComponentJohnson & Johnson Professionals, Inc.1996—
−4K961939S-Rom Femoral Hip Stem (Sizes 12 X 06 X 115 and 12 X 07 X 115)Johnson & Johnson Professionals, Inc.1996—
−3K974331Uni-Rom Total Hip System Femoral StemJohnson & Johnson Professionals, Inc.1998—
−2K001991Titan Porocoat Hip ProsthesisDePuy Orthopaedics, Inc.2000—
−1K042992Corail Amt Hip ProsthesisDePuy Orthopaedics, Inc.20051
0 (this device)K080991Depuy Asr XL Modular Acetabular Cup SystemDePuy Orthopaedics, Inc.2008—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198510
199110
199220
199320
199430
199520
199640
199710
199810
200030
200110
200210
200510
200710
200820
FIG. 1 — Lineage of K080991, 1994–2008Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in KWA? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (7)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K040627Depuy Asr Modular Acetabular Cup System
Summary page 1
…E(S): 87 KWA SUBSTANTIALLY EQUIVALENT DePuy ASR TM Modular Acetabular Cup System DEVICE(S): (K040627) DePuy ASRTM 300 Acetabular Cup System…
DePuy Orthopaedics, Inc.200555
*K073413Depuy Asr 300 Acetabular Cup System
Summary page 1
…(K040627) DePuy ASRTM 300 Acetabular Cup System (K073413) Wright Medical Metal TRANSCEND® Arti…
DePuy Orthopaedics, Inc.200836
*K021349Metal Transcend Articulation System (Larger Sizes)
Summary page 1
…Wright Medical Metal TRANSCEND® Articulation System (Larger Sizes) (K021349) DePuy Ultima® Unipolar Head and Adapter…
Wrightmedicaltechnologyinc2002—
*K965156Ultima*Unipolar Head and Adapter Sleeves
Summary page 1
…(K021349) DePuy Ultima® Unipolar Head and Adapter Sleeves (K965156) DePuy ASR TM Taper Sleeve Adapter (K0703 59)…
Johnson & Johnson Professionals, Inc.1997—
*K070359Depuy Asr Taper Sleeve Adapter
Summary page 1
…nipolar Head and Adapter Sleeves (K965156) DePuy ASR TM Taper Sleeve Adapter (K0703 59) Corail AMT H~ Prosthesis (K042992)…
DePuy Orthopaedics, Inc.20072
*K042992Corail Amt Hip Prosthesis
Summary page 1
…65156) DePuy ASR TM Taper Sleeve Adapter (K0703 59) Corail AMT H~ Prosthesis (K042992) M T…
DePuy Orthopaedics, Inc.20051
*K073570Depuy Tri-Lock Bone Preservation Stem
Summary page 1
…T DePuy Tri-Lock Bone Preservation Stem (K073570) Page 15 of 152 DePuy ASR XL Modular Acetabular Cup System DEVI…
DePuy Orthopaedics, Inc.2008—

Also cleared against K040627: 4 other devices →

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Aug 23, 2010Not classifiedZ-1811-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1814-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1815-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1807-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1812-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1808-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1810-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1816-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1806-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1809-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1805-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Aug 23, 2010Not classifiedZ-1813-2011Device DesignAs part of our ongoing post-market surveillance of all products, DePuy is continually evaluating data from a variety of sources including national joint replacement registries, published literature, company sponsored clinical trials…
Mar 5, 2010Not classifiedZ-2048-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2033-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2055-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2038-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2049-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2056-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2053-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2057-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2058-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2050-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2037-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2044-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2031-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2042-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2054-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-203-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2046-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2059-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2051-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2035-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2047-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2032-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2043-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2040-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2039-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2045-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2041-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2052-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…
Mar 5, 2010Not classifiedZ-2036-2010OtherNotification to clinicians of new revision rate data/information regarding the use of the device. As part of the post-market surveillance, DePuy is continually evaluating data from a variety of sources including national joint replacement…

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 14 years and passes through 3 companies; a new generation was cleared every 2.5 years on median.
  • 5 of the 32 ancestors have a recall of any class.
  • 4 other devices also cite its predicate K040627.

How does its category compare?

All KWA devices

KWA Prosthesis, Hip, Semi-Constrained (Metal Uncemented Acetabular Component): FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · KWA

4in 2012

2007: 82008: 92009: 72010: 62011: 112012: 4
2007high 11 (2011) · low 0 (2013)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · KWA

76in 2012

2007: 74 days median2008: 57 days median2009: 139 days median2010: 167 days median2011: 101 days median2012: 76 days median
2007high 167 (2010) · low 57 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · KWA

19in 2023

2008: 132010: 842011: 282012: 212013: 12016: 12017: 12018: 12019: 22020: 12023: 19
2007high 84 (2010) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · KWA

1,216in 2025

2007: 2132008: 7622009: 8202010: 3,3482011: 17,7372012: 24,6012013: 20,0202014: 16,4942015: 12,3392016: 7,8722017: 6,8472018: 6,3882019: 7,6282020: 4,5382021: 2,0642022: 1,6172023: 1,4742024: 1,1682025: 1,216
2007high 24,601 (2012) · low 213 (2007)2025

MAUDE reports naming product code KWA, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20078740213
200895713762
200971390820
20106167843,348
2011111012817,737
20124762124,601
20130—120,020
20140—016,494
20150—012,339
20160—17,872
20170—16,847
20180—16,388
20190—27,628
20200—14,538
20210—02,064
20220—01,617
20230—191,474
20240—01,168
20250—01,216
20260—0—

What is it indicated for?

The DePuy ASR XL Modular Acetabular Cup System is indicated for use in the following conditions, where there is evidence of sufficient sound bone to seat and support the components:

1. A severely painful and/or disabled joint from osteoarthritis, traumatic arthritis, rheumatoid arthritis, or congenital hip dysplasia.

2. Avascular necrosis of the femoral head.

3. Acute traumatic fracture of the femoral head and neck.

4. Failed previous hip surgery, including internal fixation, arthrodesis and hemi-arthroplasty.

5. Certain cases of ankylosis.

Porous-coated DePuy ASR XL Modular Acetabular Cups are indicated for cementless application.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K080991: Depuy Asr XL Modular Acetabular Cup System.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K080991

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026